OPEN END TURBO OPTIONSSCHEIN - EDWARDS LIFESCIENCES | Delayed Börse Stuttgart 02:47:16 2024-06-11 pm EDT | ||
| 1.25 EUR | -9.42% |
|
| Current month | -3.10% | ||
| 1 month | -5.30% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-06-11 | 1.25 | -9.42% |
| 24-06-10 | 1.38 | +13.11% |
| 24-06-07 | 1.22 | +0.83% |
| 24-06-06 | 1.21 | -1.63% |
| 24-06-05 | 1.23 | -0.81% |
Delayed Quote Börse Stuttgart
Last update June 11, 2024 at 02:47 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JQ49W2 |
| ISIN | DE000JQ49W24 |
| Date issued | 2022-08-25 |
| Strike | 100.7 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.77 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.69 € |
|---|---|
| Lowest since issue | 0.42 € |
| Spread | 0.08 € |
| Spread % | 5.80% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
87
USD
Average target price
96.31
USD
Spread / Average Target
+10.70%
- Stock Market
- Certificates
- Certificat
